Table of Contents Table of Contents
Previous Page  27 / 1082 Next Page
Information
Show Menu
Previous Page 27 / 1082 Next Page
Page Background

S14

ESTRO 36 2017

_______________________________________________________________________________________________

Conclusion

The clinically estimated

α/β

values for prostate cancer

from an isoeffective L-Q model were inversely related only

to the proportion of patients receiving ADT. This is in

accordance with

in vitro

and

in vivo

studies demonstrating

ADT induced cell cycle arrest and induction of apoptosis in

prostate cancer, both of which results in decelerating the

tumour growth. Thus, ADT-primed prostate cancers cells

could radiobiologically mimic late-responding normal

tissues and display lower

α/β

values. This suggests a

possible selective benefit of ADT in cancer prostate

patients on HRT treatment protocols.

OC-0037 Low dose volume effect is a critical

determinant for radiation-induced lung fibrosis

G. Defraene

1

, M. La Fontaine

2

, S. Van Kranen

2

, B.

Reymen

3

, J. Belderbos

2

, J.J. Sonke

2

, D. De Ruysscher

1,3

1

KU Leuven - University of Leuven, Department of

Radiation Oncology, Leuven, Belgium

2

Netherlands Cancer Institute, Department of Radiation

Oncology, Amsterdam, The Netherlands

3

Department of Radiation Oncology MAASTRO GROW -

School for Oncology and Developmental Biology,

Maastricht University Medical Centre, Maastricht, The

Netherlands

Purpose or Objective

Severe normal lung tissue damage after (chemo)

radiotherapy, presenting as fibrotic changes, occurs in 20%

of patients and often coincides with clinical symptoms.

The mechanism of formation and/or propagation of these

lung infiltrations is not well understood. The aim of this

study was to quantify and explain lung tissue density

increase assessed by CT scans as a surrogate of lung

damage in a dataset in which unusually large prescription

doses resulted in a wide range of lung tissue doses.

Material and Methods

The dataset consisted of 75 stage I-III non-small cell lung

cancer patients from 3 institutions treated in the PET-

Boost trial: a randomized phase II study (NCT01024829).

The randomization arms were a dose escalation to the

primary tumour (PTV

prim

) as a whole (Arm A) and an

integrated boost painted to the 50% FDG PET SUV

max

subregion of PTV

prim

(Arm B), both delivered in 24

fractions. When dose constraints prevented escalation ≥72

Gy, standard treatment of 66 Gy in 24 fractions was

delivered (Arm 0). The planning CT (CT

0

), follow-up CT

(CT

fup

) +/-3 months post RT and planned dose maps (IMRT

or VMAT) corrected to equivalent doses in 2 Gy fractions

(EQD2, α/β=3Gy) were collected. A deformable

registration mapped CT

fup

to CT

0

using a multiresolution B-

spline algorithm with constraints on rigidity and

smoothness to avoid reshaping of infiltrations on CT

fup

. The

median density change in Hounsfield Units (∆HU) within

the ‘lungs minus GTV’ contour was then extracted per

dose bin of 5 Gy from the difference image (HU

fup

-HU

0

).

Prognostic factors of ∆HU were obtained through linear

regression. The studied covariates were CT

fup

timepoint

(T

fup

), total and ipsilateral lung volume (LV

tot

and LV

ipsi

),

mean lung dose, lung volumes receiving 5 Gy, 20 Gy and

40 Gy (V

5

, V

20

and V

40

), mean heart dose (MHD), heart D

max

and PTV

prim

mean dose.

Results

The average density change response curve p er study arm

is depicted in Figure 1. A saturation was only observed

above 60Gy in Arm A. The higher response in A rm 0 above

40Gy suggested that local dose is not the on ly driver of

local ∆HU risk. Prognostic factors of individ ual patient

response at 20-25Gy, 40-45Gy and 60-65Gy were therefore

searched in the combined dataset. Table 1 shows the

significant covariates. Lower LV

ipsi

was highly prognostic of

∆HU in all dose bins. The dosimetric prognostic factors

lung V

5

and MHD could explain the higher ∆HU in Arm 0

(standard RT was only delivered in presence of limiting

constraint(s)): V

5

was on average 78.9%, 64.6% and 62.8%

in Arm 0, A and B, respectively, while MHD was on average

17.9Gy, 13.4Gy and 13.1Gy, respectively. In multivariate

analysis, LV

ipsi

, V

5

and T

fup

were independent prognostic

factors for ∆HU in the 40-45Gy and 60-65Gy dose bins.

Conclusion

This study indicates that the low dose volume effect is

critical for the induction of severe lung fibrosis in high

dose regions. This supports the hypothesis of the

importance of residual lung volumes spared from low dose

for optimal repair within the whole lung.

OC-0038 Patterns in ano-rectal dose maps and the risk

of late toxicity after prostate radiotherapy

E. Onjukka

1

, C. Fiorino

2

, F. Palorini

3

, A. Cicchetti

3

, I.

Improta

2

, C. Cozzarini

4

, C. Degli Esposti

5

, P. Gabriele

6

, R.

Valdagni

7

, G. Gagliardi

1

, T. Rancati

3